by Jordana Choucair | Dec 22, 2022 | Life Sciences
The Biden administration announced it will release the prescription antiviral Tamiflu from the Strategic National Stockpile. The move is expected to help ease access to the medication as an early and severe flu season has strained resources. The administration did not...
by Jordana Choucair | Dec 22, 2022 | Life Sciences
Roche Holding AG said the FDA approved Actemra, its monoclonal antibody for treating COVID-19 in hospitalized adults. The agency’s decision comes weeks after it revoked the emergency use authorization for Eli Lilly & Co.’s monoclonal antibody...
by Jordana Choucair | Dec 20, 2022 | Life Sciences
CVS and Walgreens are limiting purchases of children’s pain-relief medicine amid rising cases of flu, COVID-19, and RSV. “Due to increased demand and various supplier challenges, over-the-counter pediatric fever reducing products are seeing constraint...
by Jordana Choucair | Dec 19, 2022 | Life Sciences
Health systems and pharmacies are running out of antibiotics, antivirals, and pediatric cold and flu medications as the worst flu season in more than a decade collides with increased RSV and COVID-19 cases. The situation started when antibiotics manufacturers like...
by Jordana Choucair | Dec 19, 2022 | Life Sciences
The Food and Drug Administration (FDA) declared a shortage of Eli Lilly & Co.’s diabetes drug Mounjaro. The FDA informed pharmacies that they should expect full shipment delays for 5-milligram doses. However, the University of Utah drug information service,...
by Jordana Choucair | Dec 19, 2022 | Life Sciences
The FDA Vaccines and Related Biological Products Advisory Committee will hold a key meeting on January 26 to discuss the state of the pandemic and whether COVID-19 vaccines need to be modified again to better limit the fast-changing virus. The FDA is looking to get...
Recent Comments